EMPA-REG: Glucose excretion and lipid mobilization - not storage - saves lives

J Diabetes Complications. 2016 May-Jun;30(4):753. doi: 10.1016/j.jdiacomp.2016.02.015. Epub 2016 Feb 23.

Authors

Nils Bruun Jørgensen¹, Jens Pedersen², Allan Arthur Vaag³

Affiliations

¹ Department of Endocrinology, Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark. Electronic address: nils.bruun.joergensen.01@regionh.dk.
² Department of Endocrinology, Hvidovre Hospital, Kettegaards Alle 30, DK-2630, Hvidovre, Denmark.
³ Department of Endocrinology, Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.

PMID: 26970674
DOI: 10.1016/j.jdiacomp.2016.02.015

No abstract available

Publication types

Letter

MeSH terms

Aged
Benzhydryl Compounds / therapeutic use*
Cardiotonic Agents / therapeutic use*
Cardiovascular Diseases / complications
Cardiovascular Diseases / metabolism
Cardiovascular Diseases / mortality
Cardiovascular Diseases / prevention & control*
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / drug therapy
Diabetes Mellitus, Type 2 / metabolism
Diabetic Angiopathies / metabolism
Diabetic Angiopathies / mortality
Diabetic Angiopathies / prevention & control
Diabetic Cardiomyopathies / metabolism
Diabetic Cardiomyopathies / mortality
Diabetic Cardiomyopathies / prevention & control*
Glucose / metabolism
Glucosides / therapeutic use*
Heart / drug effects*
Humans
Hypoglycemic Agents / therapeutic use*
Lipid Metabolism / drug effects
Myocardium / metabolism*
Randomized Controlled Trials as Topic
Sodium-Glucose Transporter 2 / metabolism
Sodium-Glucose Transporter 2 Inhibitors

Substances

Benzhydryl Compounds
Cardiotonic Agents
Glucosides
Hypoglycemic Agents
Sodium-Glucose Transporter 2
Sodium-Glucose Transporter 2 Inhibitors
empagliflozin
Glucose